Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGastroenterology Physician in Indianapolis, IN
NPI: 1730208562Primary Practice Location
INDIANA UNIVERSITY HEALTH
1701 N Senate Blvd, Indianapolis, IN
Primary Employer
IU Health Medical Group, LLC
iuhealth.org
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
IN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 55 | 66 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 35 | 38 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 31 | 31 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 28 | 107 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 19 | 19 |
Authors: Sarina Pasricha, Ryan Madanick, Cary Cotton, Evan Dellon, William Bulsiewicz
Journal: Am J Gastroenterol
Publication Date: 2012-12-18
Re: nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
Authors: Eric Orman, Paul Hayashi
Publication Date: 2013-04-18
Lead Sponsor: Indiana University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Intervention / Treatment: OTHER: Care Coordinator Intervention for Direct Intervention Group, OTHER: Care Coordinator Intervention for Standard of Care Group, OTHER: Caregiver Intervention
Lead Sponsor: Cumberland Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Ifetroban
Lead Sponsor: BioVie Inc.
Intervention / Treatment: DRUG: BIV201 continuous infusion
